Glycosylation tips the scales: Novel insights into the dual role of type-I interferons in treated HIV infection

EBioMedicine. 2020 Oct:60:103003. doi: 10.1016/j.ebiom.2020.103003. Epub 2020 Sep 24.

Authors

Marie-Kristin Raulf¹, Bernd Lepenies²

Affiliations

¹ Immunology Unit & Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine, Hannover, Germany; Institute for Parasitology, Centre for Infection Medicine, University of Veterinary Medicine, Hannover, Germany.
² Immunology Unit & Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine, Hannover, Germany. Electronic address: bernd.lepenies@tiho-hannover.de.

No abstract available

Publication types

Letter

MeSH terms

Antiretroviral Therapy, Highly Active
Antiviral Agents / pharmacology
Antiviral Agents / therapeutic use*
Biomarkers
Glycosylation / drug effects*
HIV Infections / drug therapy*
HIV Infections / metabolism*
HIV Infections / virology
HIV-1* / drug effects
Humans
Interferon Type I / pharmacology
Interferon Type I / therapeutic use*
Treatment Outcome

Substances

Antiviral Agents
Biomarkers
Interferon Type I